These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36344998)

  • 41. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening.
    Davidović M; Zielonke N; Lansdorp-Vogelaar I; Segnan N; de Koning HJ; Heijnsdijk EA
    Value Health; 2021 Mar; 24(3):353-360. PubMed ID: 33641769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.
    Nguyen CM; Bounthavong M; Mendes MA; Christopher ML; Tran JN; Kazerooni R; Morreale AP
    Pharmacoeconomics; 2012 Jul; 30(7):575-93. PubMed ID: 22640174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.
    Seo MK; Baker P; Ngo KN
    Malar J; 2014 Feb; 13():66. PubMed ID: 24564883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
    Conteh L; Patouillard E; Kweku M; Legood R; Greenwood B; Chandramohan D
    PLoS One; 2010 Aug; 5(8):e12223. PubMed ID: 20808923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore.
    Wong JZY; Chai JH; Yeoh YS; Mohamed Riza NK; Liu J; Teo YY; Wee HL; Hartman M
    BMC Health Serv Res; 2021 Apr; 21(1):379. PubMed ID: 33892705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    Mahumud RA; Alam K; Dunn J; Gow J
    PLoS One; 2019; 14(10):e0223658. PubMed ID: 31596899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial.
    Akpan E; Hossain SJ; Devine A; Braat S; Hasan MI; Tipu SMMU; Bhuiyan MSA; Hamadani JD; Biggs BA; Pasricha SR; Carvalho N
    Am J Clin Nutr; 2022 Nov; 116(5):1303-1313. PubMed ID: 36192508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines.
    Avanceña ALV; Tejano KPS; Hutton DW
    BMJ Open; 2019 Dec; 9(12):e033455. PubMed ID: 31888937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis.
    Dasgupta RR; Mao W; Ogbuoji O
    Malar J; 2022 Mar; 21(1):81. PubMed ID: 35264153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
    Ryan M; Griffin S; Chitah B; Walker AS; Mulenga V; Kalolo D; Hawkins N; Merry C; Barry MG; Chintu C; Sculpher MJ; Gibb DM
    AIDS; 2008 Mar; 22(6):749-57. PubMed ID: 18356605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of seasonal malaria chemoprevention in upper west region of Ghana.
    Nonvignon J; Aryeetey GC; Issah S; Ansah P; Malm KL; Ofosu W; Tagoe T; Agyemang SA; Aikins M
    Malar J; 2016 Jul; 15():367. PubMed ID: 27423900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.
    Assoumou SA; Tasillo A; Leff JA; Schackman BR; Drainoni ML; Horsburgh CR; Barry MA; Regis C; Kim AY; Marshall A; Saxena S; Smith PC; Linas BP
    Clin Infect Dis; 2018 Jan; 66(3):376-384. PubMed ID: 29020317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
    Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
    Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.
    Hutton G; Schellenberg D; Tediosi F; Macete E; Kahigwa E; Sigauque B; Mas X; Trapero M; Tanner M; Trilla A; Alonso P; Menendez C
    Bull World Health Organ; 2009 Feb; 87(2):123-9. PubMed ID: 19274364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incremental cost and cost-effectiveness of the addition of indoor residual spraying with pirimiphos-methyl in sub-Saharan Africa versus standard malaria control: results of data collection and analysis in the Next Generation Indoor Residual Sprays (NgenIRS) project, an economic-evaluation.
    Yukich J; Digre P; Scates S; Boydens L; Obi E; Moran N; Belemvire A; Chamorro M; Johns B; Malm KL; Kolyada L; Williams I; Asiedu S; Fomba S; Mihigo J; Boko D; Candrinho B; Muthoni R; Opigo J; Maiteki-Sebuguzi C; Rutazaana D; Shililu J; Muhanguzi A; Belay K; Kisubi J; Atuhairwe JA; Musonda P; Iwuchukwu N; Ngosa J; Chizema E; Zulu R; Kooma E; Miller J; Bennett A; Arnett K; Tynuv K; Gogue C; Wagman J; Richardson JH; Slutsker L; Robertson M
    Malar J; 2022 Jun; 21(1):185. PubMed ID: 35690756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.